A new report from the Centers for Disease Control and Prevention found that anxiety was to blame for a series of adverse effects from the Johnson & Johnson vaccine, not the shot itself.
From April 7 to 9, the CDC received reports of “anxiety-related event groups”
At four of these sites, administrators have temporarily stopped offering coronavirus vaccines due to the high relative incidence of fainting patients – 8.2 people per 100,000, according to the CDC. In comparison, 0.05 people per 100,000 faint after receiving the flu vaccine.
After interviewing 64 patients (out of 8,624) who showed these symptoms, the CDC concluded that none of the cases met their definition of serious side effects and most were resolved within 15 minutes. The researchers attributed the symptoms to anxiety, not to discrepancies between the J&J vaccine and its Pfizer and Moderna counterparts.
In fact, the main difference between Johnson & Johnson – also known as the Janssen vaccine – and other vaccines is that it requires only one dose, which the CDC suggests may be a source of increased anxiety around it.
“Because Janssen COVID-19 is given as a single dose, this vaccine may be a more attractive option for people who are disgusted with the needle,” the report said. “Therefore, some individuals seeking vaccination against Jansen COVID-19 may be more prone to anxiety-related events after being vaccinated.”
Video: More than 54% of adults in the US have been vaccinated against COVID-19 (ABC News)
Click to expand
Seizures are most concentrated among the youngest eligible group – those aged 18 to 29 years. The report finds that it can be expected, given that adolescents have the highest rate of dizziness and fainting after other vaccines.
Vaccine-recommended vaccine administrators monitor patients for at least 15 minutes after injection to monitor for anxiety-related effects.
The adverse effects described in the study were not related to the 17 cases of patients developing blood clots, which led to a national pause in the use of the J&J vaccine in mid-April. The CDC found that these cases were extremely rare and, together with the FDA, lifted the break after 10 days. The vaccine now warns women under the age of 50 about the risk of developing a blood clot.
Biden restricts travel from India as the coronavirus grows
The US vaccination campaign has recently reached a milestone, with more than 100 million people fully vaccinated, almost doubling since the end of March. And while the number of cases is declining in the United States, with the daily average being the lowest since mid-October, global virus cases peaked last week, according to the New York Times.
Much of the wave is due to a second wave in India, which now accounts for more than 40 percent of the world’s new cases, according to the Times. As Jen Kirby and Umair Irfam told Vox, Indian hospitals are in desperate need of oxygen, ventilators, beds and vaccines, with less than 2 percent of the country fully vaccinated.
The Biden administration has promised to send supplies, including raw materials for vaccine production, although some experts are calling for the abolition of intellectual property rules for coronavirus vaccines so that India, a world leader in production, can catch up. The administration is considering the option, but in the meantime the United States will impose restrictions on travel from India, starting on Tuesday.
In a statement to CNN, White House Secretary Jen Psaki said the high number of cases in India, as well as potential new options, were the reason for the policy. Foreign nationals who have been in India for the past 14 days will be temporarily banned from entering the United States. The rule will not apply to U.S. citizens, permanent residents and aid workers.